Gain Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bethesda, MD
SEC filing record 1 source field available
Fiscal year end
31 December
Gain Therapeutics, Inc. has filed 235 SEC EDGAR filings since 30 Jul 2020

SEC filing history

Showing 1-25 of 235 matching filings.

Per page
25
Current page
1
4

OWNERSHIP DOCUMENT

Filing date
17 Jul 2026
Reporting date
15 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jul 2026
Reporting date
15 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jul 2026
Reporting date
15 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jul 2026
Reporting date
15 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jul 2026
Reporting date
15 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jul 2026
Reporting date
15 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-40237

ARS

Filing date
28 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40237

DEFA14A

Filing date
28 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40237

DEF 14A

Filing date
28 Apr 2026
Reporting date
24 Jun 2026
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Mar 2026
Reporting date
24 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Mar 2026
Reporting date
24 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .